AI visibility tools measure brand mentions across every keyword associated with your topic. For a medical practice, that means thousands of queries — the vast majority of which have nothing to do with patient acquisition. Informational content. Condition explainers. Symptom checkers. Questions patients ask when they're curious, not when they're choosing a provider.

A score built on that universe tells you how often your name appears in a sea of content that will never drive revenue. It tells you almost nothing about whether you show up when it actually counts.

When these tools benchmark your visibility against competitors, they're not comparing you to other practices in your market. They're comparing you to WebMD, Healthline, the Mayo Clinic patient education library, and large academic medical centers with entire content teams publishing thousands of informational articles at scale.

These aren't competitors. They're publishers. A patient reading "what is hypothyroidism" on Healthline is not choosing between Healthline and your practice. They aren't even close to making that decision yet. But the tool counts that mention — or lack of one — the same as any other.That's a completely different question. And it requires a human to answer it.

Not all queries are equal. A patient asking "what is a thyroid" and a patient asking "best thyroid surgeon in Tampa accepting new patients" are in completely different places in their decision journey. One of those queries is worth tens of thousands of dollars in potential revenue. The other is worth nothing to a surgical practice.

Broad AI visibility tools treat both queries identically. They have no concept of procedure value, patient lifetime value, or purchase intent. A mention is a mention. That's not a visibility strategy. That's a word count.

Even among high-intent queries, not all of them are worth pursuing equally. A query that drives ten searches a month deserves a very different level of investment than one driving ten thousand. Without accounting for actual search volume, any prioritization is essentially a guess.

A significant portion of what broad AI visibility tools measure comes from AI Overview — Google's search layer that pulls from the entire web index. In many cases this represents the majority of tracked mentions. The conversational AI platforms patients are actually using to make decisions — ChatGPT, Gemini, Perplexity, Copilot, Claude, Grok — are underrepresented or measured inconsistently. The result is a score that reflects Google's broad content index far more than the platforms driving actual patient decisions.

Software can count mentions. It cannot tell you why a competitor is winning a specific query, what content gap is costing you patients, or which three pages on your website — if rewritten — would move the needle the most. That judgment requires context, expertise, and an understanding of how AI platforms actually form recommendations.

A dashboard can surface data. It cannot turn that data into a strategy.

This is the most expensive problem of all. Even if a tool tells you your score is low, it cannot tell you what to do about it. Which queries to prioritize. What content to create. What schema to implement. Which authority signals are missing. Without that, a score is just a number — interesting, maybe alarming, but ultimately useless without a plan to improve it.

You know something is wrong. You don't know what to fix first. And every month that passes, competitors who figured it out are quietly winning the patients that should be yours.

That's the gap Lowfruit was built to close.